Market Movers: Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), Stage Stores Inc. (NYSE:SSI), Black Diamond, Inc. (NASDAQ:BDE), Viad Corp (NYSE:VVI), Five Prime Therapeutics, Inc.

Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) announced that Shalini Sharp, the company’s Chief Financial Officer, will be presenting at the Cowen and Company 36th Annual Health Care Conference on Monday, March 7, 2016 at 4:00pm ET at the Boston Marriott Copley Place in Boston, MA.

Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) belongs to Healthcare sector. Its weekly performance is 4.16%. On last trading day company shares ended up at $63.38. Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) distance from 50-day simple moving average (SMA50) is 3.45%.

On 1 March, Stage Stores Inc. (NYSE:SSI) released earnings for fourth quarter that declined compared to the same period last year. The company said its earnings totaled $26.84 million, or $0.91 per share. This was lower than $43.81 million, or $1.36 per share, in last year’s fourth quarter

Stage Stores Inc. (NYSE:SSI) shares moved down -21.32% in last trading session and ended the day at $7.01. SSI Gross Margin is 26.20% and its return on assets is 2.90%. Stage Stores Inc. (NYSE:SSI) quarterly performance is -9.45%.

Black Diamond, Inc. (NASDAQ:BDE) will hold a conference call on Monday, March 14, 2016 at 5:00 p.m. Eastern time to discuss its financial results for the fourth quarter and full year ended December 31, 2015. The financial results will be reported in a press release after the close of regular stock market trading hours on the same day as the conference call.

On 03 March, Black Diamond, Inc. (NASDAQ:BDE) shares advanced 0.66% and was closed at $4.60. BDE EPS growth in last 5 year was 0.70%. Black Diamond, Inc. (NASDAQ:BDE) year to date (YTD) performance is 4.07%.

On 1 March, Viad Corp (NYSE:VVI) announced that it has amended its credit agreement to provide the Company with increased financial flexibility to pursue its strategic growth plan and enhance shareholder value.

Viad Corp (NYSE:VVI) ended the last trading day at $29.50. Company weekly volatility is calculated as 2.51% and price to cash ratio as 7.89. Viad Corp (NYSE:VVI) showed a weekly performance of 7.04%.

Five Prime Therapeutics, Inc. (NASDAQ:FPRX) will report its fourth quarter and full year 2015 financial results on Thursday, March 10, 2016, after the U.S. financial markets close. Five Prime will host a conference call and live audio webcast on Thursday, March 10, 2016 at 5:00 p.m. (ET)/2:00 p.m. (PT) to discuss the company’s financial results and provide a general business update.

Five Prime Therapeutics, Inc. (NASDAQ:FPRX) shares moved down -7.84% in last trading session and ended the day at $33.49. FPRX return on assets is -29.50%. Five Prime Therapeutics, Inc. (NASDAQ:FPRX) quarterly performance is -12.05%.

Leave a Reply

Your email address will not be published. Required fields are marked *